Targeted radionuclide therapy is one of the most intensively developing directions of nuclear
medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy …

Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing
of cancer cells is achieved with the use of biological vectors and appropriate radionuclides …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

This review describes strategies for the delivery of therapeutic radionuclides to tumor sites.
Therapeutic approaches are summarized in terms of tumor location in the body, and tumor …

Advances in the field of molecular biology have had an impact on biomedical applications,
which provide greater hope for both imaging and therapeutics. Work has been intensified on …

Radionuclide therapy is a promising modality for treatment of tumours of haematopoietic
origin while the success for treatment of solid tumours so far has been limited. The authors …

The targeted delivery of radionuclides to tumours holds great promise for diagnosis and
treatment of malignant neoplasms. The development of scaffold proteins has significantly …

During the last decades, new radionuclide-based targeted therapies have emerged as
efficient tools for cancer treatment. Targeted radionuclide therapies (TRTs) are based on a …

Current progress in nanomedicine has exploited the possibility of designing tumor‐targeted
nanocarriers being able to deliver radionuclide payloads in a site or molecular selective …

Cancer is the second leading cause of death in the world. Radiolabeled nanocarriers or
nanoparticles can be designed and used for cancer diagnostic and therapeutic purposes …